The IFNγ activated CLL cells most prominently and demonstrated exceptional cytoprotective properties against venetoclax, surpassing even BCR- (PMA/ionomycin) and CD40L-mediated cytoprotection. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.